-A A +A

On September 29, 2021, the C.D. Howe Institute invited trusted experts in both the public and private sectors to participate in a Special Policy Seminar on the sustainability and resiliency of Canada’s pharmaceutical supply chains and other issues surrounding domestic manufacturing.

The general consensus among participants found that improving emergency preparedness, increasing domestic manufacturing capacity, and investment in the monitoring of drug supply inventories would all be beneficial for supply chain resiliency. Beyond this, the participants agreed there is a role for government to provide leadership, oversight, and investment in vaccine development and manufacturing, while also promoting public policy that contributes to growth in the bio-tech and life-science sectors.

Full Communiqué: CR_Pharma_2021 new.pdf